Is MBTN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of MBTN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate MBTN's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate MBTN's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MBTN?
Key metric: As MBTN is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for MBTN. This is calculated by dividing MBTN's market cap by their current
revenue.
What is MBTN's PS Ratio?
PS Ratio
1x
Sales
CHF 86.86m
Market Cap
CHF 86.99m
MBTN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Sales vs Industry: MBTN is good value based on its Price-To-Sales Ratio (1x) compared to the European Semiconductor industry average (1.7x).
Price to Sales Ratio vs Fair Ratio
What is MBTN's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
MBTN PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
1x
Fair PS Ratio
0.03x
Price-To-Sales vs Fair Ratio: MBTN is expensive based on its Price-To-Sales Ratio (1x) compared to the estimated Fair Price-To-Sales Ratio (0x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst MBTN forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
CHF 2.70
CHF 6.03
+123.1%
48.3%
CHF 8.10
CHF 1.00
n/a
4
Dec ’25
CHF 0.47
CHF 6.03
+1,195.7%
48.3%
CHF 8.10
CHF 1.00
n/a
4
Nov ’25
CHF 1.45
CHF 6.03
+314.7%
48.3%
CHF 8.10
CHF 1.00
n/a
4
Oct ’25
CHF 1.70
CHF 6.03
+254.4%
48.3%
CHF 8.10
CHF 1.00
n/a
4
Sep ’25
CHF 1.85
CHF 26.52
+1,333.3%
158.4%
CHF 120.00
CHF 1.00
n/a
6
Aug ’25
CHF 5.17
CHF 27.94
+441.0%
137.2%
CHF 120.00
CHF 7.50
n/a
7
Jul ’25
CHF 7.01
CHF 46.07
+557.2%
95.5%
CHF 120.00
CHF 7.50
n/a
7
Jun ’25
CHF 7.65
CHF 42.38
+453.9%
99.7%
CHF 120.00
CHF 7.50
n/a
8
May ’25
CHF 8.63
CHF 75.00
+769.6%
87.5%
CHF 202.50
CHF 7.50
n/a
7
Apr ’25
CHF 18.75
CHF 93.21
+397.1%
66.6%
CHF 202.50
CHF 7.50
n/a
7
Mar ’25
CHF 58.20
CHF 188.44
+223.8%
84.4%
CHF 562.50
CHF 37.50
n/a
8
Feb ’25
CHF 83.85
CHF 192.50
+129.6%
78.1%
CHF 562.50
CHF 37.50
n/a
9
Jan ’25
CHF 146.63
CHF 458.33
+212.6%
35.1%
CHF 607.50
CHF 202.50
n/a
9
Dec ’24
CHF 166.05
CHF 523.50
+215.3%
21.9%
CHF 645.00
CHF 225.00
CHF 0.47
10
Nov ’24
CHF 180.30
CHF 523.50
+190.4%
21.9%
CHF 645.00
CHF 225.00
CHF 1.45
10
Oct ’24
CHF 278.25
CHF 534.75
+92.2%
16.2%
CHF 645.00
CHF 337.50
CHF 1.70
10
Sep ’24
CHF 290.70
CHF 510.68
+75.7%
24.5%
CHF 645.00
CHF 225.00
CHF 1.85
11
Aug ’24
CHF 394.13
CHF 529.09
+34.2%
24.1%
CHF 667.50
CHF 270.00
CHF 5.17
11
Jul ’24
CHF 453.00
CHF 529.77
+16.9%
23.7%
CHF 675.00
CHF 270.00
CHF 7.01
11
Jun ’24
CHF 437.63
CHF 526.36
+20.3%
25.2%
CHF 675.00
CHF 232.50
CHF 7.65
11
May ’24
CHF 432.38
CHF 526.36
+21.7%
25.2%
CHF 675.00
CHF 232.50
CHF 8.63
11
Apr ’24
CHF 482.25
CHF 513.33
+6.4%
28.1%
CHF 690.00
CHF 232.50
CHF 18.75
9
Mar ’24
CHF 521.25
CHF 500.00
-4.1%
31.4%
CHF 720.00
CHF 232.50
CHF 58.20
9
Feb ’24
CHF 476.25
CHF 440.63
-7.5%
38.1%
CHF 690.00
CHF 157.50
CHF 83.85
8
Jan ’24
CHF 401.63
CHF 435.94
+8.5%
37.0%
CHF 652.50
CHF 157.50
CHF 146.63
8
Dec ’23
CHF 381.00
CHF 427.50
+12.2%
39.9%
CHF 652.50
CHF 157.50
CHF 166.05
7
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.